11Slide thumbnail
10-1Slide thumbnail
Slide backgroundSlide thumbnail
Slide backgroundSlide thumbnail
Slide backgroundSlide thumbnail
Slide backgroundSlide thumbnail
Slide backgroundSlide thumbnail
Slide backgroundSlide thumbnail
Slide backgroundSlide thumbnail
Slide backgroundSlide thumbnail

Remaining Time to the Opening of the Congress

INTERNATIONAL CONGRESS

CANCER PREVENTION & EARLY DETECTION

INTEGRATION OF RESEARCH & ACTION

Tehran, I.R. of Iran

ORGANIZER: NATIONAL CANCER RESEARCH NETWORK OF IRAN (CRNIR)

  28-30 January 2017

  GOALS:

  • To create a platform for networking of the cancer stakeholders and researchers to integrate researches to policy and action
  • To critically review the recent national policies and actions in prevention and early detection
  • To present the trend of the main cancer prevention measures in the country
  • To put forward the recent scientific achievements about cancer prevention in Iran
  • To review the most important international scientific advices and recommendations
  • To join the World Cancer Day and organize public awareness events

 

INVITED INTERNATIONAL ORGANIZATIONS:

 

ORGANIZING COMMITTEE

  • Dr. Reza Malekzadeh, Deputy of Research, Ministry of Health (Honorary Chair)
  • Dr. Mohammad Ali Mohagheghi, Director of the National Cancer Research Network (Chair)
  • Dr. Kazem Zendehdel (Scientific Director)
  • Directors of 40 CRNIR member organizations

 

Congress Venue:

Conference Center Central Office of Tehran University of Medical Sciences (TUMS), Tehran, Iran
Address: Ghods Street, Keshavarz Boulevard, Tehran, Iran

poster-en-NEW-instit-1024

International Speakers

Dr. Asmus Hammerich
Coordinator for Noncommunicable Diseases at the WHO/EMRO

WHO EMRO Recommendations on Cancer Prevention & Early Detection

The WHO Eastern Mediterranean Region (EMR) consists of 22 countries.

Read more...

Mr. Massoud Samiei
Former Head of the “Programme of Action for Cancer Therapy(PACT) , International Agency of Atomic Energy (IAEA); Delegate of the IAEA/PACT in the Congress. Opening Speech: Cancer Control Program in Low and Middle  Income Countries

Dr Elisabete Weiderpass: MD, MSc, PhD,
Head, Department of Research, Head, Group of Etiological Cancer Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway; Professor of Epidemiology, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Breast cancer: screen or not to screen?

Breast cancer is the most common cause of death from cancer in women worldwide,

Read more...

Dr. Harri Vainio
The Former Director General of the Finnish Institute of Occupational Health (FIOH) 2003-2015

A Cause of  Silent Cancer Epidemics  – Air Pollution

The WHO has estimated that air pollution was responsible for more than 7 million deaths in 2015 – roughly one in nine deaths globally.

Read more...

Dr. Behnoush Abedi-Ardekani, MD_Pathologist,
International Agency for Research on Cancer (IARC)_WHO
Genetic Cancer Susceptibility Group

The Promise of Circulating Cell-Free DNA as a Biomarker: our Experience From IARC

Recent advances in sequencing technology provide new insights on the molecular features of cancers. In one side, new promising therapeutic approaches have been discovered. On the other side, early detection and screening biomarkers are attractive subject as a breakthrough in our strategy for approaching the malignancies.

Read more...

Dr. Faris Farassati, Ph.D, Pharm.D,
Cancer Scientist, Neuro-oncology Researcher
Marion and Henry Bloch Foundation

Prevention of Cancer Progression by Targeting Cancer Stem Cell
According to the recent models for tumor development, a fraction of cells within each tumor play the role of stem cells (i.e. cancer stem cells or CSCs) and are in charge of giving rise to all other kinds of cells needed to maintain tumor integrity.

Read more...

etemadi

Dr. Arash Etemadi, MD PhD
Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

  • The molecular epidemiology of polycyclic aromatic hydrocarbons (PAHs)
  • Esophageal cancer: precancerous lesions and early detection

Read more...

Dr. Mohammad R. Akbari, M.D, Ph.D
Toronto University, Canada

Population-Based Genetic Testing For Cancer

Genetic testing for cancer predisposition is now a standard component of clinical practice in oncology. Inherited mutations in BRCA1 and BRCA2 are responsible for 5-10% of all breast cancers and 10-15% of all ovarian cancer cases.

Read more...

Ms. Gemma Lyons
Technical Officer – Cancer Control Programme World Health Organization, Cairo, Egypt

  • Recommendations for Early Detection of Colorectal Cancer in the Eastern Mediterranean Region
  • Recommendations for Early Detection of Breast Cancer in the Eastern Mediterranean Region
  • Recommendations for Early Detection of Cervical Cancer in the Eastern Mediterranean Region

Read more...

Dr. Reza Ghiasvand,
Oslo Centre for Biostatistics and Epidemiology, Faculty of Medicine, University of Oslo, Norway

Risk Factors and Prevention Strategies For Malignant Melanoma: Experience Form Northern Europe and Implication for Iran

Cutaneous melanoma is the most lethal form of skin cancer. Although it is responsible for only 4% of all skin cancers, 80% of the skin cancer deaths are due to melanoma.

Read more...

SPONSORS

International Organizations

Main Internal Sponsors